Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes

BACKGROUND: Juvenile idiopathic arthritis (JIA) treatment is aimed at inducing remission to prevent joint destruction and disability. However, it is unclear what is the long-term impact on health-related outcomes of the timing of biological disease-modifying antirheumatic drug (bDMARD) initiation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira Ramos, Filipa, Rodrigues, Ana Maria, Melo, Ana Teresa, Aguiar, Francisca, Brites, Luísa, Azevedo, Soraia, Duarte, Ana Catarina, Gomes, José António Melo, Furtado, Carolina, Mourão, Ana Filipa, Sequeira, Graça, Cunha, Inês, Figueira, Ricardo, Santos, Maria José, Fonseca, João Eurico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512498/
https://www.ncbi.nlm.nih.gov/pubmed/37735435
http://dx.doi.org/10.1186/s13075-023-03166-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512498/
https://www.ncbi.nlm.nih.gov/pubmed/37735435
http://dx.doi.org/10.1186/s13075-023-03166-9

Ejemplares similares